YAU-RCC Spotlight: can we train immunity to cure RCC? Lessons from a neoantigen vaccine trial
Minerva Urol Nephrol
.
2025 Jun;77(3):425-427.
doi: 10.23736/S2724-6051.25.06511-5.
Authors
Veronica Mollica
1
,
Riccardo Campi
2
3
,
Daniele Amparore
4
;
EAU Young Academic Urologists (YAU) Renal Cancer Working Group
Collaborators
EAU Young Academic Urologists (YAU) Renal Cancer Working Group
:
Riccardo Bertolo
,
Leonardo D Borregales
,
Anna Caliò
,
Umberto Carbonara
,
Chiara Ciccarese
,
Giulio Francolini
,
Laura Marandino
,
Margue Gaelle
,
Michele Marchioni
,
Carlotta Palumbo
,
Savio D Pandolfo
,
Angela Pecoraro
,
Eduard Roussel
,
Hannah Warren
,
Zhenjie Wu
,
Ronan Flippot
,
Giuseppe Rosiello
,
Zine-Eddine Khene
Affiliations
1
Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy - veronica.mollica7@gmail.com.
2
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
3
Urological Robotic Surgery and Renal Transplantation Unit, Careggi Hospital, University of Florence, Florence, Italy.
4
Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.
PMID:
40528781
DOI:
10.23736/S2724-6051.25.06511-5
No abstract available